A CD45‐based barcoding approach to multiplex mass‐cytometry (CyTOF)
CyTOF enables the study of the immune system with a complexity, depth, and multidimensionality never achieved before. However, the full potential of using CyTOF can be limited by scarce cell samples. Barcoding strategies developed based on direct labeling of cells using maleimido‐monoamide‐DOTA (m‐D...
Saved in:
Published in | Cytometry. Part A Vol. 87; no. 4; pp. 369 - 374 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
John Wiley & Sons, Ltd
01.04.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | CyTOF enables the study of the immune system with a complexity, depth, and multidimensionality never achieved before. However, the full potential of using CyTOF can be limited by scarce cell samples. Barcoding strategies developed based on direct labeling of cells using maleimido‐monoamide‐DOTA (m‐DOTA) provide a very useful tool. However, using m‐DOTA has some inherent problems, mainly associated with signal intensity. This may be a source of uncertainty when samples are multiplexed. As an alternative or complementary approach to m‐DOTA, conjugating an antibody, specific for a membrane protein present on most immune cells, with different isotopes could address the issues of stability and signal intensity needed for effective barcoding. We chose for this purpose CD45, and designed experiments to address different types of cultures and the ability to detect extra‐ and intra‐cellular targets. We show here that our approach provides an useful alternative to m‐DOTA in terms of sensitivity, specificity, flexibility, and user‐friendliness. Our manuscript provides details to effectively barcode immune cells, overcoming limitations in current technology and enabling the use of CyTOF with scarce samples (for instance precious clinical samples). © 2015 The Authors. Published by Wiley Periodicals, Inc. |
---|---|
AbstractList | CyTOF enables the study of the immune system with a complexity, depth, and multidimensionality never achieved before. However, the full potential of using CyTOF can be limited by scarce cell samples. Barcoding strategies developed based on direct labeling of cells using maleimido-monoamide-DOTA (m-DOTA) provide a very useful tool. However, using m-DOTA has some inherent problems, mainly associated with signal intensity. This may be a source of uncertainty when samples are multiplexed. As an alternative or complementary approach to m-DOTA, conjugating an antibody, specific for a membrane protein present on most immune cells, with different isotopes could address the issues of stability and signal intensity needed for effective barcoding. We chose for this purpose CD45, and designed experiments to address different types of cultures and the ability to detect extra- and intra-cellular targets. We show here that our approach provides an useful alternative to m-DOTA in terms of sensitivity, specificity, flexibility, and user-friendliness. Our manuscript provides details to effectively barcode immune cells, overcoming limitations in current technology and enabling the use of CyTOF with scarce samples (for instance precious clinical samples). copyright 2015 The Authors. Published by Wiley Periodicals, Inc. CyTOF enables the study of the immune system with a complexity, depth, and multidimensionality never achieved before. However, the full potential of using CyTOF can be limited by scarce cell samples. Barcoding strategies developed based on direct labeling of cells using maleimido‐monoamide‐DOTA (m‐DOTA) provide a very useful tool. However, using m‐DOTA has some inherent problems, mainly associated with signal intensity. This may be a source of uncertainty when samples are multiplexed. As an alternative or complementary approach to m‐DOTA, conjugating an antibody, specific for a membrane protein present on most immune cells, with different isotopes could address the issues of stability and signal intensity needed for effective barcoding. We chose for this purpose CD45, and designed experiments to address different types of cultures and the ability to detect extra‐ and intra‐cellular targets. We show here that our approach provides an useful alternative to m‐DOTA in terms of sensitivity, specificity, flexibility, and user‐friendliness. Our manuscript provides details to effectively barcode immune cells, overcoming limitations in current technology and enabling the use of CyTOF with scarce samples (for instance precious clinical samples). © 2015 The Authors. Published by Wiley Periodicals, Inc. CyTOF enables the study of the immune system with a complexity, depth, and multidimensionality never achieved before. However, the full potential of using CyTOF can be limited by scarce cell samples. Barcoding strategies developed based on direct labeling of cells using maleimido-monoamide-DOTA (m-DOTA) provide a very useful tool. However, using m-DOTA has some inherent problems, mainly associated with signal intensity. This may be a source of uncertainty when samples are multiplexed. As an alternative or complementary approach to m-DOTA, conjugating an antibody, specific for a membrane protein present on most immune cells, with different isotopes could address the issues of stability and signal intensity needed for effective barcoding. We chose for this purpose CD45, and designed experiments to address different types of cultures and the ability to detect extra- and intra-cellular targets. We show here that our approach provides an useful alternative to m-DOTA in terms of sensitivity, specificity, flexibility, and user-friendliness. Our manuscript provides details to effectively barcode immune cells, overcoming limitations in current technology and enabling the use of CyTOF with scarce samples (for instance precious clinical samples). CyTOF enables the study of the immune system with a complexity, depth, and multidimensionality never achieved before. However, the full potential of using CyTOF can be limited by scarce cell samples. Barcoding strategies developed based on direct labeling of cells using maleimido-monoamide-DOTA (m-DOTA) provide a very useful tool. However, using m-DOTA has some inherent problems, mainly associated with signal intensity. This may be a source of uncertainty when samples are multiplexed. As an alternative or complementary approach to m-DOTA, conjugating an antibody, specific for a membrane protein present on most immune cells, with different isotopes could address the issues of stability and signal intensity needed for effective barcoding. We chose for this purpose CD45, and designed experiments to address different types of cultures and the ability to detect extra- and intra-cellular targets. We show here that our approach provides an useful alternative to m-DOTA in terms of sensitivity, specificity, flexibility, and user-friendliness. Our manuscript provides details to effectively barcode immune cells, overcoming limitations in current technology and enabling the use of CyTOF with scarce samples (for instance precious clinical samples).CyTOF enables the study of the immune system with a complexity, depth, and multidimensionality never achieved before. However, the full potential of using CyTOF can be limited by scarce cell samples. Barcoding strategies developed based on direct labeling of cells using maleimido-monoamide-DOTA (m-DOTA) provide a very useful tool. However, using m-DOTA has some inherent problems, mainly associated with signal intensity. This may be a source of uncertainty when samples are multiplexed. As an alternative or complementary approach to m-DOTA, conjugating an antibody, specific for a membrane protein present on most immune cells, with different isotopes could address the issues of stability and signal intensity needed for effective barcoding. We chose for this purpose CD45, and designed experiments to address different types of cultures and the ability to detect extra- and intra-cellular targets. We show here that our approach provides an useful alternative to m-DOTA in terms of sensitivity, specificity, flexibility, and user-friendliness. Our manuscript provides details to effectively barcode immune cells, overcoming limitations in current technology and enabling the use of CyTOF with scarce samples (for instance precious clinical samples). |
Author | Lai, Liyun Ong, Raymond Albani, Salvatore Li, Juntao |
Author_xml | – sequence: 1 givenname: Liyun surname: Lai fullname: Lai, Liyun organization: Singapore Health Services Pte Ltd – sequence: 2 givenname: Raymond surname: Ong fullname: Ong, Raymond organization: Singapore Health Services Pte Ltd – sequence: 3 givenname: Juntao surname: Li fullname: Li, Juntao organization: Singapore Health Services Pte Ltd – sequence: 4 givenname: Salvatore surname: Albani fullname: Albani, Salvatore organization: Duke‐NUS Graduate Medical School |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25645694$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkctq3DAUhkVIya3ddV28TCEz0d2jTWFwboXAbKaLrsSRrElUbMuVPG29yyPkGfMktTvJkAYaujoHzvf_53aIdpvQOITeEzwlGNNT23dhClNKJcc76IAIQSdcMby7zSndR4cpfcOYCczoHtqnQnIhFT9Al_OsOOPi4e7eQHJlZiDaUPrmJoO2jQHsbdaFrF5XnW8r9yurIaUBHpvWrot9dlz0y8XFx7fozQqq5N49xiP05eJ8WVxNrheXn4v59cQKOsMTia1lymLqSmlBGsnUqhSGqBWGmXEUSskpkVwyVkqQJTeGcEmUIfkMc-DsCH3a-LZrU7vSuqaLUOk2-hpirwN4_Xel8bf6JvzQXOZYKjUYHD8axPB97VKna5-sqypoXFgnTWTO2IzkIv8PdGB5rsTo-uH5WNt5ng49ACcbwMaQUnSrLUKwHv-ox5Nq0H_-OOD0BW59B50P41K--peIb0Q_feX6Vxvo4utyMd_IfgO88bOF |
CitedBy_id | crossref_primary_10_1177_2472630319834057 crossref_primary_10_4049_jimmunol_1600727 crossref_primary_10_3389_fimmu_2020_615091 crossref_primary_10_1016_j_cell_2021_04_039 crossref_primary_10_1038_s41385_021_00469_5 crossref_primary_10_1038_nprot_2017_155 crossref_primary_10_1002_cyto_a_23621 crossref_primary_10_1136_gutjnl_2017_315485 crossref_primary_10_4155_bio_15_257 crossref_primary_10_1002_eji_201970107 crossref_primary_10_1038_s41598_021_91816_w crossref_primary_10_1016_j_csbj_2020_03_024 crossref_primary_10_1038_s41598_020_70492_2 crossref_primary_10_1016_j_csbj_2021_05_032 crossref_primary_10_1016_j_xpro_2022_101697 crossref_primary_10_3389_fimmu_2020_578176 crossref_primary_10_1155_2019_6705949 crossref_primary_10_1016_j_jacc_2018_08_2148 crossref_primary_10_1038_s41569_021_00589_2 crossref_primary_10_3389_fimmu_2020_01602 crossref_primary_10_1186_s13059_018_1603_1 crossref_primary_10_7554_eLife_79016 crossref_primary_10_1002_cyto_a_23014 crossref_primary_10_1002_cyto_a_24543 crossref_primary_10_1038_s41598_017_03610_2 crossref_primary_10_1136_jitc_2022_004717 crossref_primary_10_1002_cyto_a_24308 crossref_primary_10_1002_eji_201646632 crossref_primary_10_1371_journal_pone_0194593 crossref_primary_10_1038_s41584_019_0338_z crossref_primary_10_1038_s41467_022_29122_w crossref_primary_10_1172_jci_insight_143283 crossref_primary_10_3389_fimmu_2023_1182016 crossref_primary_10_1016_j_jid_2017_02_006 crossref_primary_10_1002_cyto_a_24907 crossref_primary_10_3389_fimmu_2021_674279 crossref_primary_10_1021_acs_analchem_1c03442 crossref_primary_10_1016_j_canlet_2022_215977 crossref_primary_10_1021_acs_chemrev_2c00350 crossref_primary_10_1002_cyto_a_23283 crossref_primary_10_3390_cancers14081861 crossref_primary_10_1002_cyto_a_22992 crossref_primary_10_1038_s41598_018_28791_2 crossref_primary_10_1016_j_ccell_2019_01_003 crossref_primary_10_1136_gutjnl_2018_316510 crossref_primary_10_3389_fgene_2022_1057302 crossref_primary_10_3390_cancers13215440 crossref_primary_10_1136_annrheumdis_2019_216059 crossref_primary_10_1158_1078_0432_CCR_18_4011 crossref_primary_10_1097_HC9_0000000000000508 crossref_primary_10_1038_s41591_019_0590_4 crossref_primary_10_1002_cyto_a_22876 crossref_primary_10_1016_j_ymeth_2024_11_014 crossref_primary_10_4155_bio_2016_0135 crossref_primary_10_1002_cyto_a_22717 crossref_primary_10_1073_pnas_1806695115 crossref_primary_10_1002_cyto_a_23034 crossref_primary_10_1002_eji_202048857 crossref_primary_10_1073_pnas_1706559114 crossref_primary_10_1016_j_cej_2024_154118 crossref_primary_10_1021_acs_analchem_8b03201 crossref_primary_10_1002_cyto_a_23919 |
Cites_doi | 10.1016/j.it.2012.02.010 10.1038/nmeth872 10.1002/cyto.a.22060 10.1038/nbt.2317 10.1007/s00262-013-1416-8 10.1021/bm201011t 10.1002/0471142956.cy0631s55 10.1126/science.1198704 10.1080/1042819031000151932 |
ContentType | Journal Article |
Copyright | 2015 The Authors. Published by Wiley Periodicals, Inc. 2015 The Authors. Published by Wiley Periodicals, Inc. 2015 |
Copyright_xml | – notice: 2015 The Authors. Published by Wiley Periodicals, Inc. – notice: 2015 The Authors. Published by Wiley Periodicals, Inc. 2015 |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7QO 8FD FR3 P64 5PM |
DOI | 10.1002/cyto.a.22640 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Biotechnology Research Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | Engineering Research Database CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1552-4930 |
EndPage | 374 |
ExternalDocumentID | PMC4670699 25645694 10_1002_cyto_a_22640 CYTOA22640 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: National Medical Research Council, Singapore (NMRC reference number NMRC/STaR/020/2013) |
GroupedDBID | --- -~X .3N .GA .Y3 05W 0R~ 10A 1L6 1OC 24P 2WC 31~ 33P 3SF 4.4 4ZD 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5VS 66C 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AAHQN AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABLJU ABPVW ACAHQ ACCFJ ACCZN ACFBH ACGFS ACIWK ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AUFTA AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CO8 CS3 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRSTM DU5 E3Z EBD EBS EJD EMOBN F00 F01 F04 F5P G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 P2P P2W P2X P4D Q.N QB0 QRW R.K RNS ROL RWI SUPJJ SV3 UB1 V2E W8V W99 WBKPD WIH WIK WIN WJL WNSPC WOHZO WQJ WRC WXSBR WYISQ XG1 XV2 ZZTAW ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGYGG CITATION CGR CUY CVF ECM EIF NPM 7X8 AAMMB AEFGJ AGXDD AIDQK AIDYY 7QO 8FD FR3 P64 5PM |
ID | FETCH-LOGICAL-c5280-60cc39c02ed6ca6b639fd5b19f0a8be2ad642164633d6a6d4bb14619b17804a43 |
IEDL.DBID | DR2 |
ISSN | 1552-4922 1552-4930 |
IngestDate | Thu Aug 21 18:23:14 EDT 2025 Fri Jul 11 09:28:07 EDT 2025 Fri Jul 11 04:54:11 EDT 2025 Thu Apr 03 07:02:40 EDT 2025 Tue Jul 01 00:49:15 EDT 2025 Thu Apr 24 22:58:26 EDT 2025 Wed Jan 22 16:55:22 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | barcoding multiplexing CD45 CyTOF |
Language | English |
License | Attribution-NonCommercial http://creativecommons.org/licenses/by-nc/4.0 2015 The Authors. Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5280-60cc39c02ed6ca6b639fd5b19f0a8be2ad642164633d6a6d4bb14619b17804a43 |
Notes | These authors contributed equally to this work. Conflict of Interest: The authors declare no conflicts of interest. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcyto.a.22640 |
PMID | 25645694 |
PQID | 1667347959 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4670699 proquest_miscellaneous_1673381757 proquest_miscellaneous_1667347959 pubmed_primary_25645694 crossref_primary_10_1002_cyto_a_22640 crossref_citationtrail_10_1002_cyto_a_22640 wiley_primary_10_1002_cyto_a_22640_CYTOA22640 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | April 2015 |
PublicationDateYYYYMMDD | 2015-04-01 |
PublicationDate_xml | – month: 04 year: 2015 text: April 2015 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Chichester, UK |
PublicationTitle | Cytometry. Part A |
PublicationTitleAlternate | Cytometry A |
PublicationYear | 2015 |
Publisher | John Wiley & Sons, Ltd |
Publisher_xml | – name: John Wiley & Sons, Ltd |
References | 2006; 3 2011; 12 2011; 6 2012; 33 2013; 62 2011; 332 2012; 81A 2012; 30 2004; 45 2014; 377 e_1_2_5_9_1 e_1_2_5_8_1 e_1_2_5_11_1 e_1_2_5_7_1 e_1_2_5_6_1 e_1_2_5_5_1 e_1_2_5_4_1 e_1_2_5_3_1 e_1_2_5_2_1 Zivanovic N (e_1_2_5_10_1) 2014; 377 22902532 - Nat Biotechnol. 2012 Sep;30(9):858-67 15101706 - Leuk Lymphoma. 2004 Feb;45(2):229-36 21551058 - Science. 2011 May 6;332(6030):687-96 21955116 - Biomacromolecules. 2011 Nov 14;12(11):3997-4010 23918170 - Curr Top Microbiol Immunol. 2014;377:95-109 22539147 - Cytometry A. 2012 Jul;81(7):567-75 16628206 - Nat Methods. 2006 May;3(5):361-8 23564178 - Cancer Immunol Immunother. 2013 May;62(5):955-65 22476049 - Trends Immunol. 2012 Jul;33(7):323-32 21207359 - Curr Protoc Cytom. 2011 Jan;Chapter 6:Unit 6.31 |
References_xml | – volume: 30 start-page: 858 year: 2012 end-page: 867 article-title: Multiplexed mass cytometry profiling of cellular states perturbed by small‐molecule regulators publication-title: Nat Biotechnol – volume: 45 start-page: 229 year: 2004 end-page: 236 article-title: The biology of CD45 and its use as a therapeutic target publication-title: Leuk Lymphoma – volume: 81A start-page: 567 year: 2012 end-page: 575 article-title: Human CD4+ lymphocytes for antigen quantification: Characterization using conventional flow cytometry and mass cytometry publication-title: Cytometry A – volume: 377 start-page: 95 year: 2014 end-page: 109 article-title: A practical guide to multiplexed mass cytometry publication-title: Curr Top Microbiol Immunol – volume: 33 start-page: 323 year: 2012 end-page: 332 article-title: A deep profiler's guide to cytometry publication-title: Trends Immunol – volume: 332 start-page: 687 year: 2011 end-page: 696 article-title: Single‐cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum publication-title: Science – volume: 62 start-page: 955 year: 2013 end-page: 965 article-title: An introduction to mass cytometry: Fundamentals and applications publication-title: Cancer Immunol Immunother – volume: 12 start-page: 3997 year: 2011 end-page: 4010 article-title: Curious results with Palladium‐ and Platinum‐carrying polymers in mass cytometry bioassays and an unexpected application as a dead cell stain publication-title: Biomarcomolecules – volume: 6 year: 2011 article-title: Fluorescent cell barcoding for multiplex flow cytometry publication-title: Curr Protoc Cytom – volume: 3 start-page: 361 year: 2006 end-page: 368 article-title: Fluorescent cell barcoding in flow cytometry allows high‐throughput drug screening and signaling profiling publication-title: Nat Methods – ident: e_1_2_5_2_1 doi: 10.1016/j.it.2012.02.010 – ident: e_1_2_5_5_1 doi: 10.1038/nmeth872 – ident: e_1_2_5_7_1 doi: 10.1002/cyto.a.22060 – ident: e_1_2_5_8_1 doi: 10.1038/nbt.2317 – ident: e_1_2_5_3_1 doi: 10.1007/s00262-013-1416-8 – ident: e_1_2_5_11_1 doi: 10.1021/bm201011t – ident: e_1_2_5_4_1 doi: 10.1002/0471142956.cy0631s55 – volume: 377 start-page: 95 year: 2014 ident: e_1_2_5_10_1 article-title: A practical guide to multiplexed mass cytometry publication-title: Curr Top Microbiol Immunol – ident: e_1_2_5_6_1 doi: 10.1126/science.1198704 – ident: e_1_2_5_9_1 doi: 10.1080/1042819031000151932 – reference: 21207359 - Curr Protoc Cytom. 2011 Jan;Chapter 6:Unit 6.31 – reference: 23564178 - Cancer Immunol Immunother. 2013 May;62(5):955-65 – reference: 21551058 - Science. 2011 May 6;332(6030):687-96 – reference: 21955116 - Biomacromolecules. 2011 Nov 14;12(11):3997-4010 – reference: 22902532 - Nat Biotechnol. 2012 Sep;30(9):858-67 – reference: 23918170 - Curr Top Microbiol Immunol. 2014;377:95-109 – reference: 15101706 - Leuk Lymphoma. 2004 Feb;45(2):229-36 – reference: 22539147 - Cytometry A. 2012 Jul;81(7):567-75 – reference: 16628206 - Nat Methods. 2006 May;3(5):361-8 – reference: 22476049 - Trends Immunol. 2012 Jul;33(7):323-32 |
SSID | ssj0035032 |
Score | 2.374625 |
Snippet | CyTOF enables the study of the immune system with a complexity, depth, and multidimensionality never achieved before. However, the full potential of using... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 369 |
SubjectTerms | Adult Antibodies - immunology barcoding CD45 CyTOF Flow Cytometry - methods Humans Leukocyte Common Antigens - analysis Leukocyte Common Antigens - immunology Leukocytes, Mononuclear - cytology Mass Spectrometry - methods multiplexing Staining and Labeling Technical Note |
Title | A CD45‐based barcoding approach to multiplex mass‐cytometry (CyTOF) |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcyto.a.22640 https://www.ncbi.nlm.nih.gov/pubmed/25645694 https://www.proquest.com/docview/1667347959 https://www.proquest.com/docview/1673381757 https://pubmed.ncbi.nlm.nih.gov/PMC4670699 |
Volume | 87 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1dSxwxFL1UoeCL1Vp1a5UUWlBk1mwmk908LttupVAtsoI-hXwNSutM0Vno9qk_ob-xv6S581W3UkHfBuaGTCb3zj3J3JwD8EZLZ0RILZFDPkQuWPgOpjSOBpZ5SrUN6zfc7_h0JA5P-cez5KzecMOzMBU_RLvhhpFRfq8xwLW5OfhLGmpnRd7VXTwIikt2LNdCTHTSskfFCS31yZBkLOKSsbruPTQ_uN14PiPdgZl3qyVvo9gyDY2fgWoGUFWffOlOC9O1P_7hdnz8CFdguUaoZFi51Co88dlzeFppVs7W4MOQjN7x5PfPX5gAHTEhUnJMgKShJydFTpo6xe_kKqDzYIy9XPniekZ2R7PJ8XjvBZyO309Gh1GtxhDZhA3CGpNaG0tLmXfCamECtEldYnoypXpgPNMOz8wKLuLYCS0cNwY1w6XpIceR5vE6LGZ55jeBWGMNja2j_dRyrVMtvBTS8VSmzAQn6cB-MyPK1lTlqJjxVVUky0zhQyutylfTgbet9beKouM_dq-byVUhhvDHiM58Pr1RPdQ-5ai6fp9NP0Y2w6TfgY3KIdreGFLyCMk70J9zldYAObzn72SXFyWXd8hTVMjQb1R6wr0DUKPzyfGwvHz5QPstWApIL6lKjl7BYnE99dsBTRVmBxYY_7xTRs4fNV0fXw |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZbxMxEB6hIgQv3Ecoh5FAAqFNHa_XiR-jQAjQQ0KpVJ5cXysQ7W5VNlLDEz-B38gvweM9aKiohHhbacfyej3jmbHH3wfwVEtnRHAtiUM8RC5YWAdzmiYjyzyl2ob8Dfc7trbFbJe_28v2Gp5TvAtT40N0G25oGXG9RgPHDemN36ihdlmVfd3Hm6AhZ7-IpN4xp_rQ4UelGY0MZQgzlnDJWFP5HtpvnG696pPOBJpn6yVPx7HREU2vwX47hLr-5Et_UZm-_fYHuuN_jPE6XG2CVDKuteoGXPDFTbhU01Yub8GbMZm84tnP7z_QBzpigrGU6ANJi1BOqpK0pYon5DAE6EEYezn01fGSPJ8s5zvTF7dhd_p6PpklDSFDYjM2CmkmtTaVljLvhNXChOgmd5kZyJzqkfFMO7w2K7hIUye0cNwYpA2XZoAwR5qnd2CtKAt_D4g11tDUOjrMLdc618JLIR3PZc5M0JMevGynRNkGrRxJMw5UjbPMFH600ir-mh4866SPapSOv8g9aWdXBTPCsxFd-HLxVQ2Q_pQj8fp5MsMUAQ2zYQ_u1hrR9cYQlUdI3oPhiq50Agjjvfqm-PwpwnkHV0WFDP0mURXOHYCafJzvjOPj_X-UfwyXZ_OtTbX5dvv9OlwJgV9WVyA9gLXqeOEfhuCqMo-iAf0CPB4iow |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Lb9QwEICtqqiIC1CeW9piJJBAKFuv43jXx9Vul_JqEdpK7cnyKwLRJlXJSt2e-hP4jfwSZvKiS0UluEXKWI7jmczYGX9DyHOjvJXgWiKPPEQhOXwHUxZHA8cDY8bB-g33Oz7uyp198e4gOag33PAsTMWHaDfc0DLK7zUa-IlPt35DQ928yLumiwdBYcl-Q0CPqNXjzy0-Kk5YWaAMKWORUJzXie_Qfuty60WXdCXOvJoueTmMLf3Q5A7RzQiq9JNv3Vlhu-78D7jj_w_xLrldh6h0WOnUKlkK2T2yUhWtnN8nb4Z0NBbJz4sf6AE9tWAqOXpA2vDJaZHTJlHxjB5DeA7C2MtxKE7n9OVoPt2bvHpA9ifb09FOVJdjiFzCB7DIZM7FyjEevHRGWohtUp_YnkqZGdjAjcdDs1LIOPbSSC-sxaLhyvYQcmRE_JAsZ3kWHhPqrLMsdp71UyeMSY0MSiovUpVyC1rSIa-bGdGuZpVjyYwjXVGWucaH1kaXr6ZDXrTSJxWj4y9yz5rJ1WBE-GfEZCGffdc9LH4qsOz6dTL9GHGGSb9DHlUK0fbGkckjleiQ_oKqtAII8V68k339UsK8wVExqaDfqNSEawegR4fTvWF5ufaP8k_JzU_jif7wdvf9E3ILor6kSj9aJ8vF6SxsQGRV2M3SfH4B5zshWw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+CD45-based+barcoding+approach+to+multiplex+mass-cytometry+%28CyTOF%29&rft.jtitle=Cytometry.+Part+A&rft.au=Lai%2C+Liyun&rft.au=Ong%2C+Raymond&rft.au=Li%2C+Juntao&rft.au=Albani%2C+Salvatore&rft.date=2015-04-01&rft.issn=1552-4930&rft.eissn=1552-4930&rft.volume=87&rft.issue=4&rft.spage=369&rft_id=info:doi/10.1002%2Fcyto.a.22640&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-4922&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-4922&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-4922&client=summon |